Credit Suisse Maintains Outperform on IVERIC bio, Raises Price Target to $18

Credit Suisse analyst Tiago Fauth maintains IVERIC bio (NASDAQ:ISEE) with a Outperform and raises the price target from $15 to $18.

Credit Suisse analyst Tiago Fauth maintains IVERIC bio (NASDAQ:ISEE) with a Outperform and raises the price target from $15 to $18.

Total
0
Shares
Related Posts